Skip to main content
Biora Therapeutics, Inc. (BIORQ)
OTCMKTS · Delayed Price · Currency is USD
0.1350
0.00 (0.00%)
May 12, 2025, 4:00 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Molecular Testing Products
4.00K
Log In
Log In
Log In
Log In
Molecular Testing Products Growth
-98.69%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States
4.00K
Log In
Log In
Log In
Log In
United States Growth
-98.69%
Log In
Log In
Log In
Log In